Next-generation bone health: How TBS Osteo and TBS Reveal can work together

Watch Prof. Didier Hans and Prof. Karen Hind walk through the Medimaps ecosystem: From TBS Osteo’s next-generation software to the opportunistic screening approach behind TBS Reveal

Medimaps receives CE MDR certification for TBS Reveal, bringing opportunistic bone-fragility assessment to routine X-rays

TBS Reveal™ is designed to help shift bone care from reaction to prevention: To surface fragility risk before the first fracture, rather than diagnosing osteoporosis only after a break has occurred.

New Study in The Lancet’s eClinicalMedicine Demonstrates Strong Potential for Identifying Bone Fragility Risk from Routine X-Rays

Findings support the use of routine X-rays to help identify individuals at very high bone fragility risk who may benefit from further bone health evaluation.

How clinicians incorporate TBS into everyday practice

Hear directly from the clinical team at a large academic tertiary care center in North Carolina on what it actually looks like to bring Trabecular Bone Score into day-to-day patient care.

Medimaps Group appoints Meinhard F. Schmidt as Board Chairman; adds Anne Le Grand and five additional board members

Meinhard F. Schmidt, an international MedTech/BioTech and digital health executive with 25+ years of experience, has been named Board Chairman.